company background image
A009290

Kwang Dong Pharmaceutical KOSE:A009290 Stock Report

Last Price

₩6.19k

Market Cap

₩255.1b

7D

1.5%

1Y

-13.9%

Updated

02 Dec, 2022

Data

Company Financials
A009290 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

A009290 Stock Overview

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea.

Kwang Dong Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kwang Dong Pharmaceutical
Historical stock prices
Current Share Price₩6,190.00
52 Week High₩8,190.00
52 Week Low₩5,480.00
Beta0.94
1 Month Change1.14%
3 Month Change-6.64%
1 Year Change-13.91%
3 Year Change-6.92%
5 Year Change-28.52%
Change since IPO190.63%

Recent News & Updates

Shareholder Returns

A009290KR PharmaceuticalsKR Market
7D1.5%2.0%1.6%
1Y-13.9%-24.0%-19.2%

Return vs Industry: A009290 exceeded the KR Pharmaceuticals industry which returned -24% over the past year.

Return vs Market: A009290 exceeded the KR Market which returned -19.2% over the past year.

Price Volatility

Is A009290's price volatile compared to industry and market?
A009290 volatility
A009290 Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.6%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market3.9%

Stable Share Price: A009290 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: A009290's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19631,006Sung-Won Choihttps://www.ekdp.com

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods.

Kwang Dong Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kwang Dong Pharmaceutical's earnings and revenue compare to its market cap?
A009290 fundamental statistics
Market Cap₩255.11b
Earnings (TTM)₩23.62b
Revenue (TTM)₩1.41t

10.8x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A009290 income statement (TTM)
Revenue₩1.41t
Cost of Revenue₩1.13t
Gross Profit₩277.73b
Other Expenses₩254.11b
Earnings₩23.62b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)574.85
Gross Margin19.66%
Net Profit Margin1.67%
Debt/Equity Ratio25.8%

How did A009290 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

17%

Payout Ratio

Does A009290 pay a reliable dividends?

See A009290 dividend history and benchmarks
When do you need to buy A009290 by to receive an upcoming dividend?
Kwang Dong Pharmaceutical dividend dates
Ex Dividend DateDec 28 2022
Dividend Pay DateApr 19 2023
Days until Ex dividend25 days
Days until Dividend pay date137 days

Does A009290 pay a reliable dividends?

See A009290 dividend history and benchmarks